TITLE

Circulating Angiopoietin-2 Is a Marker for Early Cardiovascular Disease in Children on Chronic Dialysis

AUTHOR(S)
Shroff, Rukshana C.; Price, Karen L.; Kolatsi-Joannou, Maria; Todd, Alexandra F.; Wells, David; Deanfield, John; Johnson, Richard J.; Rees, Lesley; Woolf, Adrian S.; Long, David A.
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cardiovascular disease (CVD) is increasingly recognised as a complication of childhood chronic kidney disease (CKD) even in the absence of diabetes and hypertension. We hypothesized that an alteration in angiopoietin-1 and -2, growth factors which regulate endothelial and vascular function could be involved. We report that the endothelial survival factor, angiopoietin-1 is low in children with pre-dialysis CKD whereas the pro-inflammatory angiopoietin-2 is elevated in children on dialysis. In dialysis patients, angiopoietin-2 positively correlated with time on dialysis, systolic blood pressure, and carotid artery intima media thickness. Elevated angiopoietin-2 levels in dialysis versus pre-dialysis CKD patients were also associated with an anti-angiogenic (high soluble VEGFR-1 and low VEGF-A) and pro-inflammatory (high urate, E-selectin, P-selectin and VCAM-1) milieu. Ang-2 was immunodetected in arterial biopsy samples whilst the expression of VEGF-A was significantly downregulated in dialysis patients. Serum urate correlated with angiopoietin-2 levels in dialysis patients and addition of uric acid was able to induce rapid release of angiopoietin-2 from cultured endothelial cells. Thus, angiopoietin-2 is a marker for cardiovascular disease in children on chronic dialysis and may act as an anti-angiogenic and pro-inflammatory effector in this context. The possibility that the release of angiopoietin-2 from endothelia is mediated by urate should be explored further.
ACCESSION #
87624450

 

Related Articles

  • Pre-Dialysis Systolic Blood Pressure-Variability Is Independently Associated with All-Cause Mortality in Incident Haemodialysis Patients. Selvarajah, Viknesh; Pasea, Laura; Ojha, Sanjay; Wilkinson, Ian B.; Tomlinson, Laurie A. // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Systolic blood pressure variability is an independent risk factor for mortality and cardiovascular events. Standard measures of blood pressure predict outcome poorly in haemodialysis patients. We investigated whether systolic blood pressure variability was associated with mortality in incident...

  • Etiology and outcome of chronic renal failure in Indian children. Gulati, S.; Mittal, Sanjay; Sharma, Raj Kumar; Gupta, Amit // Pediatric Nephrology;1999, Vol. 13 Issue 7, p594 

    A prospective analysis of all new pediatric cases of chronic renal failure (CRF) was performed at our hospital over a 1-year period. The diagnosis of CRF was based on serum creatinine >2 mg/dl with supportive clinical, laboratory, and radiological findings. There were a total of 48 patients with...

  • Effect of Erythropoiesis-Stimulating Agents on Blood Pressure in Pre-Dialysis Patients. Suttorp, Marit M.; Hoekstra, Tiny; Mittelman, Moshe; Ott, Ilka; Franssen, Casper F. M.; Dekker, Friedo W. // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Introduction: Erythropoiesis-Stimulating Agents (ESA) are hypothesized to increase cardiovascular mortality in patients with chronic kidney disease. One of the proposed mechanisms is the elevation of blood pressure (BP) by ESA. Therefore, we aimed to determine whether the use of ESA was...

  • Angiopoietin-2 Is Associated with Albuminuria and Microinflammation in Chronic Kidney Disease. Chang, Fan-Chi; Lai, Tai-Shuan; Chiang, Chih-Kang; Chen, Yung-Ming; Wu, Ming-Shiou; Chu, Tzong-Shinn; Wu, Kwan-Dun; Lin, Shuei-Liong // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Although cardiovascular disease (CVD) is the leading cause of mortality in patients with chronic kidney disease (CKD), the pathophysiology is not thoroughly understood. Given that elevated albuminuria or circulating angiopoietin-2 associates with CVD and mortality in CKD patients, we were...

  • Improved left ventricular mass index in children after renal transplantation. Becker-Cohen, Rachel; Nir, Amiran; Ben-Shalom, Efrat; Rinat, Choni; Feinstein, Sofia; Farber, Benjamin; Frishberg, yaacov // Pediatric Nephrology;Sep2008, Vol. 23 Issue 9, p1545 

    Left ventricular hypertrophy (LVH) is a risk factor for cardiovascular disease, and it is prevalent in children with end-stage renal disease (ESRD) and after renal transplantation (RTx) on cross-sectional studies. Our aim was to compare prospectively left ventricular mass index (LVMI) in...

  • Hemodiafiltration for vancomycin overdose in a neonate with end-stage renal failure. Goebel, J.; Ananth, M.; Lewy, J. E. // Pediatric Nephrology;1999, Vol. 13, p423 

    We describe continuous venovenous hemodiafiltration (CVVHD) with a high-flux membrane as a novel treatment modality for vancomycin overdose associated with renal insufficiency. CVVHD was used in a 6-day-old male with a solitary hypodysplastic kidney, suspected sepsis, and anuric renal failure...

  • Improved growth velocity with intensive dialysis. Consequence or coincidence? Katz, A.; Bock, Glenn H.; Mauer, Michael // Pediatric Nephrology;Aug2000, Vol. 14 Issue 8/9, p710 

    Growth failure in children with end-stage renal disease remains a difficult problem. A 2.5-month-old baby in renal failure due to primary hyperoxaluria type I received intensive dialysis aimed at decreasing oxalate tissue accretion. Over 5.5 months, while awaiting transplantation, his growth...

  • Kidney transplantation in young children: should there be a minimum age? Humar, A.; Arrazola, L.; Mauer, M.; Matas, A. J.; Najarian, J. S. // Pediatric Nephrology;Dec2001, Vol. 16 Issue 12, p941 

    The optimal age for transplantation in children with end-stage renal disease remains controversial. Many centers have adopted a policy of waiting until such children reach a certain minimum age or weight, maintaining them on chronic dialysis until then. Their policy is based on historical data...

  • Renal failure in Nigerian children: factors limiting access to dialysis. Wasiu Adekunle Olowu, Lesley // Pediatric Nephrology;Dec2003, Vol. 18 Issue 12, p1249 

    A 5-year clinical and laboratory study of Nigerian children with renal failure (RF) was performed to determine the factors that limited their access to dialysis treatment and what could be done to improve access. There were 48 boys and 33 girls (aged 20 days to 15 years). Of 81 RF patients, 55...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics